Phase 1 Higher Risk Myelodysplastic Syndromes Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

Acute Lymphoblastic LeukaemiaHigher Risk Myelodysplastic SyndromesAcute Myeloid Leukaemia

AstraZeneca84 enrolled30 locationsNCT07155226

Recruiting

Phase 1

Study of REM-422 in Patients With AML or Higher Risk MDS

Acute Myeloid LeukemiaMyelodysplastic SyndromesAcute Myeloid Leukemia, Refractory+1 more

Remix Therapeutics100 enrolled9 locationsNCT06297941

Recruiting

Phase 1Phase 2

VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS

Higher Risk Myelodysplastic Syndromes

Navy General Hospital, Beijing54 enrolled1 locationNCT06471946